Clinically, Beclin1 has been reported to be positively or negatively correlated with a poor or better survival status in distinct solid malignancies.43, 44, 45 In this study, Beclin1 was found to act as an oncogene to promote radioresistance in patients with SCCHN. This evidence concerns the gene BECN1 and head and neck squamous cell carcinoma.